GLP-2 Tirzepatide 10mg/20mg/30mg

Tirzepatide is a novel peptide compound studied for its potential effects on metabolic regulation and glucose control. It functions as a dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors—two pathways that play key roles in insulin sensitivity, appetite regulation, and energy balance.

Research has shown interest in Tirzepatide for its ability to support studies related to weight management, improved metabolic efficiency, and enhanced glucose metabolism. Its dual-receptor action has made it a leading subject of investigation within metabolic and endocrine research.